| 1 |
刘军.持续炎症-免疫抑制-分解代谢综合征的共识与争议[J].中华医学杂志，2019，99（13）：961-964.
|
| 2 |
李维勤.脓毒症诊疗的新挑战——持续炎症、免疫抑制和分解代谢综合征[J].医学研究生学报，2017，30（7）：673-677.
|
| 3 |
Desarmenien M, Blanchard-Courtois AL, Ricou B. The chronic critical illness: a new disease in intensive care[J]. Swiss Med Wkly, 2016 (146): w14336.
|
| 4 |
Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care[J]. J Trauma Acute Care Surg, 2012, 72 (6): 1491-1501.
|
| 5 |
Rosenthal MD, Moore FA. Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): a new phenotype of multiple organ failure[J]. J Adv Nutr Hum Metab, 2015, 1 (1): e784.
|
| 6 |
夏然，童兴瑜，张成密，等.持续炎症-免疫抑制-分解代谢综合征研究进展[J/CD].中华危重症医学杂志（电子版），2020，13（2）：149-153.
|
| 7 |
Hu D, Ren J, Wang G, et al. Persistent inflammation-immunosuppression catabolism syndrome, a common manifestation of patients with enterocutaneous fistula in intensive care unit [J]. J Trauma Acute Care Surg, 2014, 76 (3): 725-729.
|
| 8 |
Kahn JM, Le T, Angus DC, et al. The epidemiology of chronic critical illness in the United States[J]. Crit Care Med, 2015, 43 (2): 282-287.
|
| 9 |
杨娜，李维勤.慢重症新诊断标准及治疗进展[J/CD].中华危重症医学杂志（电子版），2016，9（3）：197-200.
|
| 10 |
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 775-787.
|
| 11 |
Sundar KM, Sires M. Sepsis induced immunosuppression: implications for secondary infections and complications [J]. Indian J Crit Care Med, 2013, 17 (3): 162-169.
|
| 12 |
Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management[J]. BMJ, 2016 (353): i1585.
|
| 13 |
Drewry AM, Hotchkiss RS. Sepsis: revising definitions of sepsis[J]. Nat Rev Nephrol, 2015, 11 (6): 326-328.
|
| 14 |
Horiguchi H, Loftus TJ, Hawkins RB, et al. Innate immunity in the persistent inflammation, immunosuppression, and catabolism syndrome and its implications for therapy[J]. Front Immunol, 2018 (9): 595.
|
| 15 |
Fan X, Liu Z, Jin H, et al. Alterations of dendritic cells in sepsis: featured role in immunoparalysis[J]. Biomed Res Int, 2015: 903720.
|
| 16 |
Bhardwaj N, Mathur P, Kumar S, et al. Depressed monocytic activity may be a predictor for sepsis[J]. J Lab Physicians, 2015, 7 (1): 26-31.
|
| 17 |
Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?[J]. J Clin Invest, 2016, 126 (1): 23-31.
|
| 18 |
苏和毅，莫泽珣，刘星，等.内科重症监护病房中继发持续性炎症-免疫抑制-分解代谢综合征的老年脓毒症患者回顾性分析[J].中华老年医学杂志，2019，38（8）：869-874.
|
| 19 |
杨建钢，杨玉彬，刘清华.脓毒性休克患者早期主要炎性因子水平及其临床意义[J].中华危重病急救医学，2019，31（6）：680-683.
|
| 20 |
梁伟智，陈灿，李理，等.免疫功能对脓毒症患者预后的影响[J].中华危重病急救医学，2018，30（12）：1128-1131.
|
| 21 |
Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome[J]. Crit Care Med, 2017, 45 (2): 253-262.
|
| 22 |
De Backer D, Cecconi M, Lipman J, et al. Challenges in the management of septic shock: a narrative review[J]. Intensive Care Med, 2019, 45 (4): 420-433.
|
| 23 |
丁仁彧，邱佳男，刘宝燕，等.持续性炎症-免疫抑制-分解代谢综合征63例临床分析[J].中华内科杂志，2016，55（12）：941-944.
|
| 24 |
陈辉，杨毅.持续性炎症-免疫抑制-分解代谢综合征：重症感染的真凶？[J].中华内科杂志，2015，54（8）：670-671.
|
| 25 |
肖春红，张再重，宋京翔，等.营养支持治疗在慢性危重症治疗中的作用[J].中华胃肠外科杂志，2019，22（11）：1016-1020.
|
| 26 |
刘正才，杨西胜.脓毒症营养支持治疗策略[J].中华消化外科杂志，2019，18（10）：920-923.
|